DALACINE 900 mg, solution for injection ampoule, 6 ml
Active ingredients: Clindamycin phosphate, Clindamycin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionampoule, 6 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DALACINE 900 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 ampoule(s) en verre de 6 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Oct 2002
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60978355CIP75619767CIP133400956197675Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLINDAMYCINE (PHOSPHATE DE)solution | — | SA |
| CLINDAMYCINE BASEsolution | 900 mg · 6 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.